119 related articles for article (PubMed ID: 8222486)
1. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
Smith LJ; Glass M; Minkwitz MC
Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
[TBL] [Abstract][Full Text] [Related]
3. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics.
Dahlén B; Zetterström O; Björck T; Dahlén SE
Eur Respir J; 1994 Feb; 7(2):324-31. PubMed ID: 8162986
[TBL] [Abstract][Full Text] [Related]
4. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
[TBL] [Abstract][Full Text] [Related]
5. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
Schelfhout V; Van De Velde V; Pauwels R; Joos G
Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
[TBL] [Abstract][Full Text] [Related]
6. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
Findlay SR; Barden JM; Easley CB; Glass M
J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246
[TBL] [Abstract][Full Text] [Related]
7. Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma.
Nathan RA; Glass M; Minkwitz MC
Chest; 1994 Feb; 105(2):483-8. PubMed ID: 8306751
[TBL] [Abstract][Full Text] [Related]
8. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT
Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176
[TBL] [Abstract][Full Text] [Related]
9. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
Wahedna I; Wisniewski AS; Tattersfield AE
Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
[TBL] [Abstract][Full Text] [Related]
10. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
Smith LJ; Hanby LA; Lavins BJ; Simonson SG
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
[TBL] [Abstract][Full Text] [Related]
11. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
Spector SL; Smith LJ; Glass M
Am J Respir Crit Care Med; 1994 Sep; 150(3):618-23. PubMed ID: 8087328
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
Makker HK; Lau LC; Thomson HW; Binks SM; Holgate ST
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1413-8. PubMed ID: 8389103
[TBL] [Abstract][Full Text] [Related]
13. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
[TBL] [Abstract][Full Text] [Related]
14. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
[TBL] [Abstract][Full Text] [Related]
15. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
[TBL] [Abstract][Full Text] [Related]
16. The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.
Donnelly AL; Glass M; Minkwitz MC; Casale TB
Am J Respir Crit Care Med; 1995 Jun; 151(6):1734-9. PubMed ID: 7767514
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
Frølund L; Madsen F; Nielsen J
Allergy; 1991 Jul; 46(5):355-61. PubMed ID: 1928658
[TBL] [Abstract][Full Text] [Related]
18. The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics.
Joos GF; Kips JC; Pauwels RA; Van der Straeten ME
Pulm Pharmacol; 1991; 4(1):37-42. PubMed ID: 1804493
[TBL] [Abstract][Full Text] [Related]
19. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.
Finnerty JP; Wood-Baker R; Thomson H; Holgate ST
Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):746-9. PubMed ID: 1554195
[TBL] [Abstract][Full Text] [Related]
20. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.
Hui KP; Barnes NC
Lancet; 1991 May; 337(8749):1062-3. PubMed ID: 1673495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
